Osaic Holdings’s CollPlant Biotechnologies CLGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$120 Hold
35
﹤0.01% 7822
2026
Q1
$184 Buy
35
+1
+3% +$10 ﹤0.01% 7575
2025
Q4
$469 Hold
34
﹤0.01% 7449
2025
Q3
$1.03K Hold
34
﹤0.01% 7337
2025
Q2
$455 Sell
34
-6
-15% -$124 ﹤0.01% 7369
2025
Q1
$1.03K Buy
40
+21
+111% +$740 ﹤0.01% 6805
2024
Q4
$684 Sell
19
-18
-49% -$732 ﹤0.01% 6935
2024
Q3
$1.79K Buy
37
+17
+85% +$832 ﹤0.01% 6656
2024
Q2
$994 Buy
+20
New +$1.11K ﹤0.01% 6819
2022
Q2
Sell
-25
Closed -$3K 7364
2022
Q1
$3K Hold
25
﹤0.01% 6713
2021
Q4
$4K Buy
+25
New +$4.46K ﹤0.01% 6734

Other funds holding CLGN

Osaic Holdings's CLGN Position: Q2 2026 in Review

Osaic Holdings held its CollPlant Biotechnologies (CLGN) position steady in Q2 2026 at 35 shares worth $120. The position accounts for ﹤0.01% of the portfolio, ranked #7822.

Osaic Holdings first reported a position in CLGN in Q4 2021 and has held it in 11 quarters since. The position peaked at $4K in Q4 2021. 15 funds tracked by Wall St. Rank hold CLGN as of Q2 2026.

  • Osaic Holdings held 35 shares of CollPlant Biotechnologies worth $120 as of Q2 2026.
  • Osaic Holdings left its CollPlant Biotechnologies share count unchanged in Q2 2026.
  • CollPlant Biotechnologies made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #7822 holding.
  • Osaic Holdings first reported a position in CollPlant Biotechnologies in Q4 2021 and has held it in 11 quarters since.
  • Osaic Holdings's CollPlant Biotechnologies position peaked at $4K in Q4 2021.
  • 15 funds tracked by Wall St. Rank held CollPlant Biotechnologies as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.